Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy for diagnosis of solid pancreatic lesions

R. Pittayanon, P. Kongkam, R. Rerknimitr
{"title":"Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy for diagnosis of solid pancreatic lesions","authors":"R. Pittayanon, P. Kongkam, R. Rerknimitr","doi":"10.18528/GII160025","DOIUrl":null,"url":null,"abstract":"An accurate diagnosis of solid pancreatic lesions (SPLs) is important because pancreatic cancer cannot be ignored if curative treatment is possible. Prompt and reliable diagnostic procedures are greatly needed for patients presenting with SPLs, particularly where resection is possible for a malignant mass. Several endoscopic ultrasound (EUS)-related technologies including a novel EUS-guided needle-based confocal laser endomicroscopy (EUS-nCLE) can provide real-time images at the cellular level (1,000-fold magnification). A 19-gauge EUS-guided fine needle aspiration (EUS-FNA) needle is recommended because its channel is large enough for the 0.85-mm diameter nCLE miniprobe. The procedure is performed by standard EUSFNA techniques with either preor post-loading technique. Ten percent fluorescein sodium (2.5–5 mL) is used as an enhancing agent and is intravenously injected immediately before puncturing the lesion. Only a few studies have used the technique and reported results. A recent study from 19 malignant and 3 benign SPLs classified EUS-nCLE findings according to 4 signs: dark clumps, and dilated vessels (predominantly seen in malignant SPLs) and fine white fibrous bands and normal acini (predominantly seen in benign SPLs). Using these criteria, researchers correctly diagnosed 18 of the malignant SPLs (94.7%). Another study described 2 lesions as having “dark cells aggregates with pseudo-glandular aspects, and straight hyperdense elements more or less thick corresponding to tumoral fibrosis” in 17 of 18 malignant SPLs. Thus far, no large and systematic study has been performed to evaluate the potential clinical use of EUS-nCLE for diagnosing SPLs. However, based on available information from a few studies and the current limitations of EUS-FNA, EUS-nCLE can potentially provide a complementary role in diagnosing such lesions. Nevertheless, more studies are certainly needed. Copyright © 2016, Society of Gastrointestinal Intervention. All rights reserved.","PeriodicalId":32516,"journal":{"name":"Gastrointestinal Intervention","volume":"265 1","pages":"212-215"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastrointestinal Intervention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18528/GII160025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

An accurate diagnosis of solid pancreatic lesions (SPLs) is important because pancreatic cancer cannot be ignored if curative treatment is possible. Prompt and reliable diagnostic procedures are greatly needed for patients presenting with SPLs, particularly where resection is possible for a malignant mass. Several endoscopic ultrasound (EUS)-related technologies including a novel EUS-guided needle-based confocal laser endomicroscopy (EUS-nCLE) can provide real-time images at the cellular level (1,000-fold magnification). A 19-gauge EUS-guided fine needle aspiration (EUS-FNA) needle is recommended because its channel is large enough for the 0.85-mm diameter nCLE miniprobe. The procedure is performed by standard EUSFNA techniques with either preor post-loading technique. Ten percent fluorescein sodium (2.5–5 mL) is used as an enhancing agent and is intravenously injected immediately before puncturing the lesion. Only a few studies have used the technique and reported results. A recent study from 19 malignant and 3 benign SPLs classified EUS-nCLE findings according to 4 signs: dark clumps, and dilated vessels (predominantly seen in malignant SPLs) and fine white fibrous bands and normal acini (predominantly seen in benign SPLs). Using these criteria, researchers correctly diagnosed 18 of the malignant SPLs (94.7%). Another study described 2 lesions as having “dark cells aggregates with pseudo-glandular aspects, and straight hyperdense elements more or less thick corresponding to tumoral fibrosis” in 17 of 18 malignant SPLs. Thus far, no large and systematic study has been performed to evaluate the potential clinical use of EUS-nCLE for diagnosing SPLs. However, based on available information from a few studies and the current limitations of EUS-FNA, EUS-nCLE can potentially provide a complementary role in diagnosing such lesions. Nevertheless, more studies are certainly needed. Copyright © 2016, Society of Gastrointestinal Intervention. All rights reserved.
超声引导下针基共聚焦激光内镜在胰腺实性病变诊断中的应用
胰脏实性病变(SPLs)的准确诊断是很重要的,因为如果有治愈治疗的可能,胰脏癌是不能忽视的。快速可靠的诊断程序是非常需要的患者提出的SPLs,特别是在恶性肿瘤切除可能。几种内镜超声(EUS)相关技术,包括一种新型的超声引导针基共聚焦激光内镜显微镜(EUS- ncle),可以提供细胞水平的实时图像(放大1000倍)。推荐使用19号eus引导的细针抽吸(EUS-FNA)针,因为它的通道足够大,可以放置直径0.85 mm的nCLE微型探针。该过程采用标准EUSFNA技术和前后加载技术进行。10%荧光素钠(2.5 - 5ml)用作增强剂,在穿刺病变之前立即静脉注射。只有少数研究使用了这种技术并报告了结果。最近一项对19例恶性和3例良性SPLs的研究根据4个征象对EUS-nCLE进行了分类:深色团块、血管扩张(主要见于恶性SPLs)、白色细纤维带和正常腺泡(主要见于良性SPLs)。使用这些标准,研究人员正确诊断出18例恶性SPLs(94.7%)。另一项研究描述了18例恶性SPLs中17例的2个病变具有“具有假腺样面的深色细胞聚集,以及或多或少与肿瘤纤维化相对应的直发高密度元素”。到目前为止,还没有进行大型系统的研究来评估EUS-nCLE诊断SPLs的潜在临床应用。然而,基于一些研究的现有信息和目前EUS-FNA的局限性,EUS-nCLE可能在诊断此类病变方面提供潜在的补充作用。然而,肯定需要更多的研究。版权所有©2016,胃肠干预学会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
24 weeks
期刊介绍: IJGII (pISSN 2636-0004, eISSN 2636-0012) was published four times a year on the last day of January, April, July, and October, which has effected from January 1 in 2019. This Journal was first published biannually on June and December, beginning in December 2012 under the title ‘Gastrointestinal Intervention’ (former pISSN 2213-1795, eISSN 2213-1809) and was changed to be published three times a year from 2016. Commencing with the January 2019 issue, the Journal was renamed ‘International Journal of Gastrointestinal Intervention’. As the official journal of the Society of Gastrointestinal Intervention (SGI), International Journal of Gastrointestinal Intervention (IJGII) delivers original, peer-reviewed articles for gastroenterologists, interventional radiologists, surgeons, gastrointestinal oncologists, nurses and technicians who need current and reliable information on the interventional treatment of gastrointestinal and hepatopancreaticobiliary diseases. Regular features also include ‘state-of-the-art’ review articles by leading authorities throughout the world. IJGII will become an international forum for the description and discussion of the various aspects of interventional radiology, endoscopy and minimally invasive surgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书